Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005

Guilford Pharmaceuticals to Announce 2004 Year-End Financial
Results on Tuesday, March 1, 2005 


BALTIMORE, Feb. 10  /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc.
(NASDAQ:GLFD) will announce its year-end 2004 financial results on Tuesday,
March 1, 2005.  The company's management will host a conference call and live
audio webcast to discuss the financial results and other business for the
upcoming year at 4:00 p.m. E.T. on Tuesday, March 1, 2005.

The press release and live webcast can be accessed by going to the Investor
Relations section of Guilford's website at http://www.guilfordpharm.com/. 
Following the webcast, an archived version of the call will be available until
March 7, 2005.

To participate in the live conference call, U.S. residents should dial
800-265-0241, international callers 617-847-8704.  The participant passcode is
99914317.

An audio replay of the conference call will be available for 48 hours beginning
at approximately 6:00 p.m. E.T. on March 1, 2005 through 11:59 p.m. on March 3,
2005.  To access the replay, U.S. residents should dial 888-286- 8010, (int'l
callers 617-801-6888), passcode 19310134.

About Guilford

Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the
research, development and commercialization of proprietary drugs that target
the hospital and neurology markets.  Presently, Guilford markets two commercial
products, GLIADEL(R) Wafer (polifeprosan 20 with carmustine implant), for the
treatment of certain types of brain tumor in combination with radiation and
surgery, and AGGRASTAT(R) Injection (tirofiban hydrochloride), a glycoprotein
GP IIb/IIIa receptor antagonist, for the treatment of acute coronary syndrome
(ACS). Guilford's product pipeline includes AQUAVAN(R) Injection, an
investigational sedative/anesthetic drug, and drugs for treating peripheral
nerve injury.  For full prescribing information, please visit
http://www.guilfordpharm.com/ under Products / Marketed Products.

CONTACT:  Stacey Jurchison, Guilford Pharmaceuticals, [phone], . 

DATASOURCE: Guilford Pharmaceuticals Inc.



CONTACT:  Stacey Jurchison, Guilford Pharmaceuticals, [phone],





Web site:  http://www.guilfordpharm.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/112882.html

Copyright